source
- FDA advisory panel backs Moderna's experimental flu vaccine in adults 50-64, supports accelerated review for 65+The FDA's advisory committee voted unanimously to recommend Moderna's mRNA-1010 flu vaccine for adults aged 50 to 64, and also found it beneficial for those 65 and older. The 9-0 vote allows Moder…
- cAMPfield Therapeutics raises $180 million to develop oral IBD drug prifemilastcAMPfield Therapeutics, a California biotech, announced a $180 million Series A financing to advance its oral anti‑inflammatory candidate for inflammatory bowel disease. The investigational drug,…